US › Healthcare

Synlogic Inc (SYBX)

US · Healthcare · Biotechnology

$1.17-2.50%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$681,000
Profit YoY
+114.8%
EPS
$-0.19

Key statistics

Market cap
$14.0M
Forward P/E
0.0
P/B
1.12
Book value
$1.07
EPS (TTM)
$-0.06
52-week high
$1.87
52-week low
$0.54
50-day MA
$0.73
200-day MA
$0.91
Beta
0.50

Analyst view

Analysts rate Synlogic Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $1.00.

Shareholding

Insiders
15.65%
Institutions
57.55%

Largest institutional holders

FundStake
DRW Securities, LLC0.20%
State Street Corp0.00%
Ikarian Capital, LLC0.00%
Susquehanna International Group, LLP0.00%
BlackRock Inc0.00%
Jane Street Group LLC0.00%
Northern Trust Corp0.00%
FMR Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Synlogic Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.